State Street
ALGS icon

State Street’s Aligos Therapeutics ALGS Stock Holding History

State Street’s Portfolio ALGS Stock Details ALGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,582
Closed -$382K – 4283
2024
Q4 		$382K Buy
+9,582
New +$185K ﹤0.01% 3691
2024
Q3 		– Sell
-4,285
Closed -$37.5K – 4297
2024
Q2 		$37.5K Buy
4,285
+388
+10% +$6.82K ﹤0.01% 4194
2024
Q1 		$95.5K Hold
3,897
– – ﹤0.01% 4037
2023
Q4 		$64.7K Hold
3,897
– – ﹤0.01% 4147
2023
Q3 		$72.8K Hold
3,897
– – ﹤0.01% 4192
2023
Q2 		$94.6K Hold
3,897
– – ﹤0.01% 4255
2023
Q1 		$85.1K Buy
3,897
+1,464
+60% +$55.9K ﹤0.01% 4371
2022
Q4 		$58K Hold
2,433
– – ﹤0.01% 4526
2022
Q3 		$67K Hold
2,433
– – ﹤0.01% 4586
2022
Q2 		$74K Sell
2,433
-13,757
-85% -$467K ﹤0.01% 4626
2022
Q1 		$870K Buy
16,190
+589
+4% +$47.2K ﹤0.01% 3852
2021
Q4 		$4.63M Buy
15,601
+632
+4% +$231K ﹤0.01% 3277
2021
Q3 		$5.8M Buy
14,969
+3,026
+25% +$1.2M ﹤0.01% 3151
2021
Q2 		$6.09M Buy
11,943
+5,057
+73% +$3.22M ﹤0.01% 3146
2021
Q1 		$3.91M Buy
6,886
+489
+8% +$325K ﹤0.01% 3157
2020
Q4 		$4.42M Buy
+6,397
New +$3.12M ﹤0.01% 3020

Other funds holding ALGS

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street's ALGS Position: Q1 2025 in Review

State Street sold out of Aligos Therapeutics (ALGS) in Q1 2025, closing a stake of 9,582 shares — an estimated $382K sold.

State Street first reported a position in ALGS in Q4 2020 and held it in 16 quarters. The position peaked at $6.09M in Q2 2021. 35 funds tracked by Wall St. Rank hold ALGS as of Q1 2025.

  • State Street reported no remaining Aligos Therapeutics position as of Q1 2025 after selling out during the quarter.
  • State Street sold 9,582 Aligos Therapeutics shares in Q1 2025, an estimated $382K.
  • State Street first reported a position in Aligos Therapeutics in Q4 2020 and held it in 16 quarters.
  • State Street's Aligos Therapeutics position peaked at $6.09M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.